Faster, lower-cost manufacturing at an industrial scale could help nucleic acid therapeutics address common genetic disorders at a cost acceptable to insurers and health systems. It could also ...

This schematic shows the secondary structure of two aptamers. The complex shapes formed by base pairing (black lines connecting G-C and A-T bases) allow aptamers to bind their targets with high ...